GSK PLC SP. ADR/2 NEW (GS70) — Defensive Interval Ratio
GSK PLC SP. ADR/2 NEW (GS70) has a Defensive Interval Ratio of 126 days as of March 2026. Defensive assets of €7.76 Billion (cash €-, short-term investments €1.00 Million, receivables €7.76 Billion) cover 126 days of daily cash needs of €61.45 Million/day. See GS70 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
GSK PLC SP. ADR/2 NEW Defensive Interval Ratio (2021–2025)
This chart shows how GSK PLC SP. ADR/2 NEW's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 126 days, meaning defensive assets of €7.76 Billion can fund 126 days of operations without new revenue. See GS70 net asset quality score to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for GSK PLC SP. ADR/2 NEW (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for GSK PLC SP. ADR/2 NEW from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market value of GSK PLC SP. ADR/2 NEW.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 101 days | €5.92 Billion | €58.61 Million/day | €- | €9.00 Million | ▲ +7 days |
| 2024 | 94 days | €5.58 Billion | €59.44 Million/day | €- | €21.00 Million | ▼ -47 days |
| 2023 | 141 days | €8.15 Billion | €57.72 Million/day | €- | €2.25 Billion | ▼ -12 days |
| 2022 | 154 days | €9.61 Billion | €62.49 Million/day | €- | €4.15 Billion | ▲ +56 days |
| 2021 | 97 days | €6.31 Billion | €64.85 Million/day | €- | €61.00 Million | — |